Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7685056 | 0.78 | MAPK1 (0.46) | MAPK1ALDH1A1ALOX15MEN1KMT2A | |
| SCHEMBL7685059 | 0.78 | MAPK1 (0.46) | MAPK1ALDH1A1ALOX15MEN1KMT2A | |
| SCHEMBL9354340 | 0.76 | MAPK1 (0.55) | MAPK1ALDH1A1ALOX15TSHRHTT | |
| SCHEMBL8934729 | 0.75 | — | — | |
| SCHEMBL8934715 | 0.70 | LMNA (0.30) | — | |
| Propane SCHEMBL481265 | 0.70 | MAPK1 (0.85) | MAPK1ALDH1A1ALOX15KMT2ATAAR1 | |
| SCHEMBL11836994 | 0.70 | MAPK1 (0.52) | MAPK1ALDH1A1ALOX15MEN1KMT2A | |
| SCHEMBL28682767 | 0.69 | MAPK1 (0.67) | MAPK1ALDH1A1ALOX15TAAR1 | |
| SCHEMBL5808591 | 0.69 | MAPK1 (0.67) | MAPK1ALDH1A1ALOX15KMT2ATSHR | |
| Butane SCHEMBL365415 | 0.68 | MAPK1 (0.81) | MAPK1ALDH1A1ALOX15KMT2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996030415-A1 | ALKOXY ALLYL (DI)PEROXIDE CHAIN TRANSFER AGENTS | AKZO NOBEL N.V. (NL) | 1996-10-03 | — | — | WO | disclosed |